Byung-Chul Suh

This inventor holds 18 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 6 EPO patents. Top assignees: Enanta Pharmaceuticals, Inc., Yuhan Corporation, Cytochroma Inc.. Active years: 2007-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Byung-Chul Suh. Retrieved from https://idiyas.com/inventor/byung-chul-suh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 18 (Patent Applications = 2)

% Patents Active = 77.8

CIPO Patents = 2 (Patent Applications = 3)

EPO Patents = 6 (Patent Applications = 7)

Average Co-Inventor Count = 9.3

ph-index = 6

Forward Citations = 89(Granted Patents)

Location History:

Cockeysville, MD (US) (2007 - 2012)
Lexington, MA (US) (2015 - 2024)

Company Filing History:

11 out of 299

Enanta Pharmaceuticals, Inc.

Janssen Biotech, Inc.

Johns Hopkins University

where one patent can have more than one assignee

Years Active: 2007-2025

Loading Chart...

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12496282 - Hepatitis B antiviral agents (2025-12-16),

2. 12398147 - Macrocyclic spiropyrrolidine derived antiviral agents (2025-08-26),

3. RE50528 - Compounds and compositions for modulating EGFR mutant kinase activities (2025-08-12),

4. 12258327 - 5-membered heteroaryl-containing aminopyridine compounds as EGFR inhibitors (2025-03-25),

5. 12011425 - Hepatitis B antiviral agents (2024-06-18),

6. 11945798 - Substituted aminopyridine compounds as EGFR inhibitors (2024-04-02),

7. 11760755 - Hepatitis B antiviral agents (2023-09-19),

8. 11596611 - Hepatitis B antiviral agents (2023-03-07),

9. 11472808 - Substituted pyrrolo[1,2-c]pyrimidines as hepatitis B antiviral agents (2022-10-18),

10. 11236111 - Hepatitis B antiviral agents (2022-02-01),

11. 10952978 - Hepatitis B antiviral agents (2021-03-23),

12. 10729688 - Hepatitis B antiviral agents (2020-08-04),

13. 10723733 - Hepatitis B antiviral agents (2020-07-28),

14. 10428070 - Hepatitis B antiviral agents (2019-10-01),

15. 9593098 - Compounds and compositions for modulating EGFR mutant kinase activities (2017-03-14),

Title: Inventor Byung-Chul Suh: Pioneering Innovations in Cockeysville

Introduction: Byung-Chul Suh is a renowned inventor based in Cockeysville, MD, known for his groundbreaking contributions to various technological fields.

Latest Patents: Byung-Chul Suh's latest patents include advancements in renewable energy technologies, smart home devices, and medical equipment, showcasing his diverse range of expertise.

Career Highlights: With a career spanning over two decades, Byung-Chul Suh has established himself as a leading figure in the innovation landscape, with numerous successful inventions that have significantly impacted industries worldwide.

Collaborations: Throughout his career, Byung-Chul Suh has collaborated with top research institutions, leading companies, and innovative startups to bring his ideas to life and drive forward technological progress.

Conclusion: Byung-Chul Suh's relentless pursuit of innovation and his passion for creating solutions to complex challenges continue to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.